Zur Hauptnavigation Zum Inhalt

Explanation of the AGES Dashboard COVID19

(Last update: 07/02/2021)

Background information on the EMS:

The Epidemiological Reporting System („Epidemiologisches Meldesystem“, EMS) is the joint database of all Austrian District Administration Authorities, Regional Health Directorates, the Ministry of Health as well as the Agency for Health and Food Safety (AGES) according to the Austrian Epidemics Act (Epidemiegesetz 1950 [ris.bka.gv.at]) § 4.

The EMS was jointly designed by the district administrative offices, the regional sanitary directorates and the Ministry of Health with the participation of AGES and ELGA GmbH (Electronic Health Records Ltd).

The EMS is a database for the necessary clinical, epidemiological and laboratory data of notifiable diseases in Austria, collected by the district administrative offices.

Since 2014, there has been an electronic reporting obligation for the laboratory reporting of all notifiable diseases in Austria. This ensures that information is transmitted as quickly and promptly as possible to the authorities (see Laboratory Reporting Duty Order [Labormeldepflicht-VO [ris.bka.gv.at]]). Doctors can also report electronically via the EHIC-card network or, alternatively, via citizen card access/mobile phone signature.

The data the AGES dashboard is drawn from is provided by the Epidemiological Reporting System (EMS), it is subjected to an additional quality check prior to use. For some depictions, as indicated below, the data is provided by the offices of the respective provincial governments of the federal states.

For information on hospitalizations (intermediate care wards, intensive care units), data reporting is done via the BMSGPK capacity survey tool, except for data on Vienna, which is extracted from another data report.

The AGES dashboard is updated daily at 14:00.


Indicators Definition
Case definition All further definitions are based on the current (07/02/2021) case definition/case classification.
Case definition: Clinical criteria: Individuals with at least one of the following symptoms: (1) cough, (2) fever, (3) shortness of breath, (4) sudden loss of taste/smell OR acute taste disturbance.
Diagnostic imaging criteria: Radiological evidence of COVID-19 compatible lesions.
Laboratory diagnostic criteria: one of the following criteria: (1) detection of SARS-CoV-2 specific nucleic acid in a clinical specimen by PCR, (2) detection of SARS-CoV-2 specific antigen in a clinical specimen by antigen test.
Epidemiologic criteria: Contact (defined as for contact person category I, II) with a confirmed case of SARS-CoV2 infection in 10 days prior to illness onset.
Case classification: Suspected case: any person meeting clinical criteria; Probable case: any person meeting clinical and epidemiologic criteria OR any person meeting diagnostic imaging criteria OR any person with detection of SARS-CoV-2 antigen; Confirmed case: Any person with detection of SARS-CoV-2 specific nucleic acid (regardless of clinical manifestation) [ECDC, Case definition for coronavirus disease 2019 (COVID-19), 12/03/2020].
Tests Cumulative number of tests carried out for SARS-CoV-2, from 27 February 2020 up to and including the reporting date.
Responsible for data consolidation: Office of the respective federal state government (Land), data status: morning of the reporting day.
Laboratory-confirmed cases Cumulative number of laboratory-confirmed cases of SARS-CoV-2 infection (sum of "Active cases", "Recovered cases" and "Deceased cases") with laboratory diagnosis date since 02/27/2020 up to and including the reporting date.
Active cases Cumulative number of laboratory-confirmed cases of SARS-CoV-2 infection with laboratory diagnosis date from 02/27/2020 up to and including the reporting date, which have not been classified as "recovered" or "deceased" on the reporting date.
Recovered cases Cumulative number of laboratory-confirmed cases of SARS-CoV-2 infection with laboratory diagnosis date from 02/27/2020 up to and including the report date, which are classified as "recovered" on the report date.
Definition of "recovered" (since 9 July): in the case of home care, 10-day home isolation after the onset of symptoms or laboratory diagnosis;
in case of severe disease progression, the earliest 10 days after onset of symptoms, at least 48 hours without symptoms AND the following result by RT-PCR according to the Charité protocol: no nucleic acid detection of beta-coronavirus SARS-CoV-2 or nucleic acid detection of beta-coronavirus SARS-CoV-2 at a Ct value of more than 30. Further details can be found in the recommendation for the release of COVID-19 cases, recommendation for the release of COVID-19 cases from isolation.
Deceased cases Cumulative number of laboratory-confirmed cases of SARS-CoV-2 infection with a laboratory diagnosis date from 02/27/2020 up to and including the report date, which are classified as "deceased" on the report date.
Definition of "deceased": COVID-19 death is defined - for surveillance purposes - as one laboratory-confirmed case of COVID-19 resulting in death, where the status "recovered" has NOT been present between the status "disease" and the status "death".
Chronological sequence Presentation of the laboratory-confirmed cases of a SARS-CoV-2 infection according to the day of laboratory diagnosis (in the absence of information on the laboratory diagnosis date, the day of the positive laboratory report is used) since 02/27/2020 up to and including the report day.
Cases by age group and sex Presentation of laboratory confirmed cases of SARS-CoV-2 infection by age group and sex
Cases by district (geographical) Presentation of laboratory-confirmed cases of a SARS-CoV-2 infection by district of the place of residence (verified according to the Austrian Central Register or, in the absence of an entry therein, by district of residence (e.g. for tourists). Data in number of cases, absolute and per 100,000 inhabitants.
7-day incidence Indication of laboratory-confirmed cases of a SARS-CoV-2 infection with laboratory diagnosis date within the past 7 days in relation to the day before the report day (report day minus 7 days up to 24h00 on the day before the report day); indication in case number, absolute and per 100,000 inhabitants
Available no. of beds in normal wards The number of beds in normal wards available for COVID-19 cases on the reporting day.
Responsible for data consolidation: Office of the respective federal state government (Land), data status: morning of the reporting day.
Available no. of beds in intensive care units The number of beds in intensive care units available for COVID-19 patients on the reporting day.
Responsible for data consolidation: Office of the respective federal state government (Land), data status: morning of the reporting day.
Active cases in the hospitals’ normal ward The number of beds in normal wards occupied by COVID-19 patients on the report day.
Responsible for data consolidation: Office of the respective federal state government (Land), data status: morning of the reporting day.
Active cases in intensive care units The number of beds in intensive care units occupied by COVID-19 patients on the day of the report.
Responsible for data consolidation: Office of the respective federal state government (Land), data status: morning of the reporting day.
Active cases in home care The number of COVID-19 patients in home care.
Responsible for data consolidation: Office of the respective federal state government (Land), data status: morning of the reporting day.
Additional available intensive care beds (incl. expandable capacity) The number of additional intensive care beds available for COVID-19 patients on the reporting day plus intensive care beds potentially available within 7 days (the total usable capacity for COVID-19 is determined by the effective demands on regular care in the respective hospitals).
Place of data aggregation: Office of the respective provincial government (federal state), data status: reporting day, morning. For Vienna, detailed information on intensive care beds potentially available within 7 days is not available due to differences in data reporting.
Additional available normal care beds (incl. expandable capacity) The number of additional standard-care beds available for COVID-19 patients on the reporting day plus standard-care beds potentially available within 7 days (the total usable capacity for COVID-19 is determined by the effective demands on regular care in the respective hospitals).
Place of data aggregation: Office of the respective provincial government (federal state), data status: reporting day, morning. For Vienna, detailed information on standard beds potentially available within 7 days is not available due to differences in data reporting.

Definitions for data collection, beds in intensive care segment - Information on LGF-funded hospitals and accident hospitals (UKH) of AUVA (data transmission of hospitals by way of the federal states to BMSGPK)

Key figures Definition
Intensive Care Units Total (total bed capacity) Number of ICU (adult) beds set up in LGF-funded hospitals and UKH (intensive monitoring and treatment E0-E3 [incl. IMCU]) -occupied and unoccupied.
ICUs, occupied with COVID-19 Number of occupied ICU (adult) beds with COVID-19 cases (confirmed COVID-19 cases, excluding suspected cases).
ICUs, occupied with non-COVID-19 ICUs, occupied with non-COVID-19 Number of occupied ICU (adult) beds with non-COVID-19 cases.
Daily actual vacant beds Result from difference' ICU bed capacity total', 'ICU beds, with COVID-19 occupied' and 'ICU beds with non-COVID-19 occupied'.